The highest dose arms demonstrated significantly greater weight loss than liraglutide 3.0 mg administered daily (~10.8% vs ~9.0%)
Quick reference for the subcodes: R13.10: unspecified, the common starting code R13.11: oral phase, bolus control R13.12: oropharyngeal phase, billed most often R13.13: pharyngeal phase, aspiration focus R13.14: pharyngoesophageal phase, the UES code R13.19: other, cervical and neurogenic ASHA's ICD-10 reference confirms the R13.1 series for dysphagia and flags when the I69 sequelae codes take over for post-stroke cases, which is where we're headed next
For androgenetic alopecia, also called male or female pattern hair loss, established options such as minoxidil and finasteride have stronger clinical support
By controlling every variable you can, from the supplier you choose to the syringe you use, you set your project up for the clearest, most valuable outcome
Brain 145 , 25552568 (2022)